应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EOLS Evolus Inc.
盘后交易 07-26 18:31:59 EDT
12.31
+0.18
+1.48%
盘后
12.31
+0.00
0.00%
16:01 EDT
最高
12.40
最低
12.05
成交量
25.04万
今开
12.34
昨收
12.13
日振幅
2.89%
总市值
7.71亿
流通市值
5.53亿
总股本
6,261万
成交额
306.60万
换手率
0.56%
流通股本
4,496万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
免疫学药物销售强劲,艾伯维上调年度盈利预期
Reuters · 07-25 19:36
免疫学药物销售强劲,艾伯维上调年度盈利预期
Evolus, Inc. Common Stock盘中异动 股价大涨5.02%报11.50美元
自选股智能写手 · 07-12
Evolus, Inc. Common Stock盘中异动 股价大涨5.02%报11.50美元
Evolus, Inc. Common Stock2024财年第一财季实现净利润-13.11百万美元,同比增加11.36%
自选股智能写手 · 05-14
Evolus, Inc. Common Stock2024财年第一财季实现净利润-13.11百万美元,同比增加11.36%
HC Wainwright & Co.:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价27.00美元。
智通财经 · 05-09
HC Wainwright & Co.:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价27.00美元。
Evolus, Inc. Common Stock盘中异动 早盘急速跳水5.92%报12.63美元
自选股智能写手 · 05-08
Evolus, Inc. Common Stock盘中异动 早盘急速跳水5.92%报12.63美元
Evolus Inc 报告截至三月的季度业绩 - 收益摘要
Reuters · 05-08
Evolus Inc 报告截至三月的季度业绩 - 收益摘要
Evolus Inc 预计每股亏损 10 美分 - 财报前瞻
Reuters · 05-04
Evolus Inc 预计每股亏损 10 美分 - 财报前瞻
Evolus, Inc. Common Stock盘中异动 急速上涨5.01%报12.36美元
自选股智能写手 · 05-01
Evolus, Inc. Common Stock盘中异动 急速上涨5.01%报12.36美元
艾伯维因 Skyrizi 销售强劲而上调年度利润预期
Reuters · 04-26
艾伯维因 Skyrizi 销售强劲而上调年度利润预期
Needham:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价22.00美元。
智通财经 · 04-10
Needham:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价22.00美元。
嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold
Reuters · 03-12
嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold
BUZZ-Evolus 在发行 5000 万美元股票后反弹
Reuters · 03-11
BUZZ-Evolus 在发行 5000 万美元股票后反弹
Evolus, Inc. Common Stock盘中异动 早盘股价大涨7.14%报15.08美元
自选股智能写手 · 03-11
Evolus, Inc. Common Stock盘中异动 早盘股价大涨7.14%报15.08美元
Evolus, Inc. Common Stock2023财年实现净利润-61.69百万美元,同比增加17.09%
自选股智能写手 · 03-10
Evolus, Inc. Common Stock2023财年实现净利润-61.69百万美元,同比增加17.09%
Evolus, Inc. Common Stock盘中异动 股价大涨5.03%报14.82美元
自选股智能写手 · 03-08
Evolus, Inc. Common Stock盘中异动 股价大涨5.03%报14.82美元
Evolus Inc盘中异动 早盘股价大跌5.20%
自选股智能写手 · 02-05
Evolus Inc盘中异动 早盘股价大跌5.20%
Evolus Inc盘中异动 早盘急速上涨6.11%
自选股智能写手 · 01-29
Evolus Inc盘中异动 早盘急速上涨6.11%
暂无数据
公司概况
公司名称:
Evolus Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Evolus, Inc.于2012年11月在特拉华州注册成立。它是一家医学美学公司,致力于为医生及其患者提供审美程序和治疗方面的更多选择。
发行价格:
--
{"stockData":{"symbol":"EOLS","market":"US","secType":"STK","nameCN":"Evolus Inc.","latestPrice":12.31,"timestamp":1722024000000,"preClose":12.13,"halted":0,"volume":250431,"hourTrading":{"tag":"盘后","latestPrice":12.31,"preClose":12.31,"latestTime":"16:01 EDT","volume":28862,"amount":355291.22000000003,"timestamp":1722024100151},"delay":0,"floatShares":44959106,"shares":62610487,"eps":-1.043545,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.18,"latestTime":"07-26 18:31:59 EDT","open":12.34,"high":12.4,"low":12.05,"amount":3066030.739896,"amplitude":0.028854,"askPrice":12.49,"askSize":100,"bidPrice":9.46,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.043545,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1722038400000},"adr":0,"listingDate":1518066000000,"adjPreClose":12.13,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":12.49,"preClose":12.13,"latestTime":"08:54 EDT","volume":1,"amount":12.49,"timestamp":1721998471322},"postHourTrading":{"tag":"盘后","latestPrice":12.31,"preClose":12.31,"latestTime":"16:01 EDT","volume":28862,"amount":355291.22000000003,"timestamp":1722024100151},"volumeRatio":0.802709,"impliedVol":0.2658,"impliedVolPercentile":0.0516},"requestUrl":"/m/hq/s/EOLS/tweets","defaultTab":"tweets","newsList":[{"id":"2454821038","title":"免疫学药物销售强劲,艾伯维上调年度盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2454821038","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454821038?lang=zh_cn&edition=full","pubTime":"2024-07-25 19:36","pubTimestamp":1721907396,"startTime":"0","endTime":"0","summary":" 路透7月25日 - 艾伯维 周四上调了年度利润预期,因为包括Humira在内的主要免疫学药物的强劲销售帮助其第二季度业绩超过了华尔街的预期。艾伯维在2月 ,预计今年Humira在美国的销售额将下降36%。该制药公司及其投资者一直关注较新的免疫学药物Skyrizi和Rinvoq的销售,以抵消Humira需求的减少。第二季度,该抗癌药的全球销售额下降了 8%,降至 8.33 亿美元,但仍超过了 7.89 亿美元的预期。调整后,艾伯维每股收益为 2.65 美元,超出预期 8 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","IE00BFSS8Q28.SGD","LU1093756168.USD","LU0965508806.USD","LU0266013472.USD","MRK","LU1934455194.USD","CVS","LU0545039389.USD","LU0158827948.USD","LU1037948897.HKD","LU1699723380.USD","LU0029864427.USD","ABBV","IE00BLSP4239.USD","LU0265550946.USD","LU1066051498.USD","LU0289739699.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00B894F039.SGD","LU1496350502.SGD","LU0211326839.USD","IE00B19Z9P08.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0868494617.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU0187121727.USD","IE00BBT3K403.USD","LU0109391861.USD","IE00B1XK9C88.USD","LU1037948541.HKD","IE0005OL40V9.USD","CI","LU1244550577.SGD","RVNC","LU1934455277.USD","LU0094547139.USD","EOLS","LU1941712348.USD","IE00BFSS7M15.SGD","LU0417517546.SGD","LU1261432733.SGD"],"gpt_icon":1},{"id":"2450396187","title":"Evolus, Inc. Common Stock盘中异动 股价大涨5.02%报11.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450396187","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450396187?lang=zh_cn&edition=full","pubTime":"2024-07-12 01:02","pubTimestamp":1720717354,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日01时02分,Evolus, Inc. Common Stock股票出现波动,股价快速上涨5.02%。截至发稿,该股报11.50美元/股,成交量14.7929万股,换手率0.24%,振幅3.20%。Evolus, Inc. Common Stock股票所在的制药行业中,整体跌幅为0.36%。Evolus, Inc. Common Stock公司简介:Evolus Inc 是一家高性能美容公司,以客户为中心,为自费美容市场提供突破性产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712010234af91e319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712010234af91e319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EOLS","BK4007"],"gpt_icon":0},{"id":"2435308365","title":"Evolus, Inc. Common Stock2024财年第一财季实现净利润-13.11百万美元,同比增加11.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435308365","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435308365?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:24","pubTimestamp":1715617488,"startTime":"0","endTime":"0","summary":"3月31日,Evolus, Inc. Common Stock公布财报,公告显示公司2024财年第一财季净利润为-13.11百万美元,同比增加11.36%;其中营业收入为59.33百万美元,同比增加42.21%,每股基本收益为-0.22美元。从资产负债表来看,Evolus, Inc. Common Stock总负债2.08亿美元,其中短期债务1.15百万美元,资产负债比为1.09,流动比率为0.04。机构评级:截至2024年3月31日,当前有7家机构对Evolus, Inc. Common Stock目标价做出预测,其中目标均价为22.29美元,其中最低目标价为16.00美元,最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400245487632671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400245487632671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EOLS"],"gpt_icon":0},{"id":"2434770994","title":"HC Wainwright & Co.:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434770994","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434770994?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:15","pubTimestamp":1715195744,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903154887e16a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903154887e16a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EOLS"],"gpt_icon":0},{"id":"2433212457","title":"Evolus, Inc. Common Stock盘中异动 早盘急速跳水5.92%报12.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433212457","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433212457?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:31","pubTimestamp":1715175086,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时31分,Evolus, Inc. Common Stock股票出现异动,股价大幅下跌5.92%。Evolus, Inc. Common Stock股票所在的制药行业中,整体涨幅为0.15%。其相关个股中,Elanco Animal Health Incorporated、Pacira Biosciences, Inc.、梯瓦制药涨幅较大,Sunshine Biopharma Inc.、苏轩堂、Akanda Corp.较为活跃,换手率分别为63.45%、13.18%、2.72%,振幅较大的相关个股有Siga Technologies Inc.、脑再生科技、Avadel Pharmaceuticals Plc,振幅分别为11.38%、7.86%、4.18%。Evolus, Inc. Common Stock公司简介:Evolus Inc 是一家高性能美容公司,以客户为中心,为自费美容市场提供突破性产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213126861ebc46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213126861ebc46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EOLS"],"gpt_icon":0},{"id":"2433871344","title":"Evolus Inc 报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433871344","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433871344?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:28","pubTimestamp":1715153300,"startTime":"0","endTime":"0","summary":" * Evolus Inc 报告了截至3月底的季度调整后每股亏损9美分,高于去年同期的每股-15美分。六位分析师对该季度的平均预期是每股亏损 10 美分。华尔街预期为每股-20美分至-5美分。* Evolus Inc 公布的本季度每股收益为亏损 22 美分。* 该公司当季亏损 1311 万美元。* Evolus Inc本季度股价下跌了4.1%,今年迄今为止上涨了27.4%。华尔街对 Evolus Inc 的 12 个月目标价中位数为 23.00 美元。本摘要由 LSEG 数据于世界协调时 5 月 8 日上午 07:28 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"gpt_icon":0},{"id":"2432153234","title":"Evolus Inc 预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432153234","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432153234?lang=zh_cn&edition=full","pubTime":"2024-05-04 06:15","pubTimestamp":1714774511,"startTime":"0","endTime":"0","summary":" * Evolus Inc 将于5月7日公布截至2024年3月31日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,6位分析师的平均预期显示,这家总部位于加利福尼亚州纽波特海滩的公司的营收预计将从去年同期的4172万美元增长37.4%,达到5732.1万美元。* LSEG分析师对Evolus公司的平均预期是每股亏损10美分。* 华尔街对 Evolus Inc 的 12 个月目标价中位数为 23.00 美元,高于其上次收盘价 13.30 美元。5月3日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS"],"gpt_icon":0},{"id":"2432307570","title":"Evolus, Inc. Common Stock盘中异动 急速上涨5.01%报12.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432307570","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432307570?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:34","pubTimestamp":1714570484,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时34分,Evolus, Inc. Common Stock股票出现波动,股价快速上涨5.01%。截至发稿,该股报12.36美元/股,成交量2.2977万股,换手率0.04%,振幅2.55%。Evolus, Inc. Common Stock股票所在的制药行业中,整体跌幅为0.04%。Evolus, Inc. Common Stock公司简介:Evolus Inc 是一家高性能美容公司,以客户为中心,为自费美容市场提供突破性产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012134457925a09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012134457925a09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EOLS","BK4007"],"gpt_icon":0},{"id":"2430501278","title":"艾伯维因 Skyrizi 销售强劲而上调年度利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430501278","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430501278?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:36","pubTimestamp":1714131396,"startTime":"0","endTime":"0","summary":"艾伯维和其投资者一直关注较新的免疫学药物Skyrizi和Rinvoq的销售情况,以抵消Humira对销售额的侵蚀--Humira是全球销量最大的药物,直到去年它失去了独家代理权,并出现了近似的仿制药。Skyrizi 的销售额为 20.1 亿美元,超过了预期的 19.4 亿美元,而 Rinvoq 的销售额为 10.9 亿美元,略高于预期的 10.6 亿美元。本季度,Humira 的销售额下降了近 36%,为 22.7 亿美元,与预期的 22.8 亿美元基本一致。本季度Imbruvica的销售收入为8.38亿美元,高于预期的7.44亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0882574055.USD","RVNC","LU1244550577.SGD","LU0256863811.USD","LU0128525929.USD","LU1057294990.SGD","LU1989771016.USD","IE0004445239.USD","LU0211331839.USD","LU1093756325.SGD","LU2361044865.SGD","IE00BLSP4239.USD","LU2468319806.SGD","LU1023059063.AUD","MRK","LU1732800096.USD","LU1585245621.USD","LU1989772840.SGD","LU1066051498.USD","LU1989772923.USD","LU2023250843.SGD","IE0002141913.USD","LU0122379950.USD","LU1267930573.SGD","SG9999001176.USD","LU2361045086.USD","ABBV","LU1093756168.USD","BK4534","LU0211327993.USD","LU1732799900.SGD","SG9999001176.SGD","LU0661504455.SGD","LU1551013425.SGD","IE00BJT1NW94.SGD","LU0965509283.SGD","LU0310799852.SGD","LU0208291251.USD","BK4533","LU1551013342.USD","LU0708994859.HKD","IE00B1BXHZ80.USD","LU0058720904.USD","LU2361044949.HKD","LU0289739699.SGD","EOLS","SG9999015341.SGD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2426469963","title":"Needham:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426469963","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426469963?lang=zh_cn&edition=full","pubTime":"2024-04-10 18:55","pubTimestamp":1712746524,"startTime":"0","endTime":"0","summary":"Needham:重申Evolus(EOLS.US)评级,由买入调整至买入评级, 目标价22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041018552687609edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041018552687609edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EOLS"],"gpt_icon":0},{"id":"2418391850","title":"嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=2418391850","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418391850?lang=zh_cn&edition=full","pubTime":"2024-03-12 02:18","pubTimestamp":1710181116,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 3月11日 - 华尔街主要股指周一下滑,投资者在等待本周的关键通胀数据,在上周喜忧参半的就业报告之后,这些数据可能为美国联邦储备局的货币政策路径提供线索。美东时间14:02,道琼斯工业平均指数 上涨0.05%,报38,742.57点。标准普尔500指数 下跌0.16%,报5,115.28点;纳斯达克综合指数 下跌0.32%,报16,033.175点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".DJI","SCX","BABA","DXD","FTRE","ML","NQmain","JD","09988","09618","PARA","NRIX","XPDB","SQQQ","MRNA","PDD","QID","RYDE","DHCAU","NFG","SDOW","QQQ","PSQ","DJX","MNQmain","LXRX","QLD","BILI","UDOW","TQQQ","ETRN","BTG","DOG","VTRS","EXK","AMD","AMPY","CHRO","WBD",".SPX",".IXIC","EOLS","H","EQT","STI","SLRN","TISI","DDM","BA","LBBB"],"gpt_icon":0},{"id":"2418369908","title":"BUZZ-Evolus 在发行 5000 万美元股票后反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=2418369908","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418369908?lang=zh_cn&edition=full","pubTime":"2024-03-11 22:54","pubTimestamp":1710168898,"startTime":"0","endTime":"0","summary":" 3月11日 - ** 医疗美容公司Evolus 周一股价上涨3.6%,报14.56美元,该公司融资5000万美元。** Evolus 还重申了 2024 财年净销售额 2.55 亿至 2.65 亿美元的指导目标,并表示预计 2024 财年第四季度和 2025 财年将实现盈利,而且现有流动资金仍然充足。** 截至 12 月底,该公司拥有约 6,300 万美元现金,而 9 月底为 3,870 万美元。** Evolus 公司周一表示,打算将股票发行的净收益用于资助 Jeuveau 公司的发展、皮肤填充剂 Evolysse 的上市活动以及其他用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EOLS","BUZZ"],"gpt_icon":0},{"id":"2418815350","title":"Evolus, Inc. Common Stock盘中异动 早盘股价大涨7.14%报15.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418815350","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418815350?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:31","pubTimestamp":1710163876,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时31分,Evolus, Inc. Common Stock股票出现波动,股价快速拉升7.14%。Evolus, Inc. Common Stock股票所在的制药行业中,整体跌幅为0.56%。Evolus, Inc. Common Stock公司简介:Evolus Inc 是一家性能美容公司,以客户为中心,在自费美容市场提供突破性产品。消息层面,截至21时31分,《Earnings Call Summary | Evolus Q4 2023 Earnings Conference》资讯为影响Evolus, Inc. Common Stock的重要信息。Evolus发布了其产品Lift、Smooth、Sculpt和Lips的令人鼓舞的临床数据,其批准申请正在美国和欧洲进行中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121311687721735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121311687721735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EOLS"],"gpt_icon":0},{"id":"2418959000","title":"Evolus, Inc. Common Stock2023财年实现净利润-61.69百万美元,同比增加17.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418959000","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418959000?lang=zh_cn&edition=full","pubTime":"2024-03-10 00:22","pubTimestamp":1710001322,"startTime":"0","endTime":"0","summary":"12月31日,Evolus, Inc. Common Stock公布财报,公告显示公司2023财年净利润为-61.69百万美元,同比增加17.09%;其中营业收入为2.02亿美元,同比增加35.57%,每股基本收益为-1.08美元。从资产负债表来看,Evolus, Inc. Common Stock总负债2.10亿美元,其中短期债务1.38百万美元,资产负债比为0.90,流动比率为0.03。机构评级:截至2023年12月31日,当前有7家机构对Evolus, Inc. Common Stock目标价做出预测,其中目标均价为22.00美元,其中最低目标价为16.00美元,最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403100022088b1cef8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403100022088b1cef8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EOLS"],"gpt_icon":0},{"id":"2417715036","title":"Evolus, Inc. Common Stock盘中异动 股价大涨5.03%报14.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417715036","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417715036?lang=zh_cn&edition=full","pubTime":"2024-03-08 02:40","pubTimestamp":1709836845,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日02时40分,Evolus, Inc. Common Stock股票出现异动,股价急速上涨5.03%。截至发稿,该股报14.82美元/股,成交量25.6851万股,换手率0.44%,振幅5.74%。Evolus, Inc. Common Stock股票所在的制药行业中,整体涨幅为0.26%。Evolus, Inc. Common Stock公司简介:Evolus Inc 是一家性能美容公司,以客户为中心,在自费美容市场提供突破性产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080240467a4a88c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080240467a4a88c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007","EOLS"],"gpt_icon":0},{"id":"2409359114","title":"Evolus Inc盘中异动 早盘股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409359114","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409359114?lang=zh_cn&edition=full","pubTime":"2024-02-05 23:03","pubTimestamp":1707145399,"startTime":"0","endTime":"0","summary":"北京时间2024年02月05日23时03分,Evolus Inc股票出现异动,股价大幅下挫5.20%。截至发稿,该股报12.77美元/股,成交量7.2572万股,换手率0.13%,振幅3.19%。Evolus Inc股票所在的制药行业中,整体涨幅为3.66%。Evolus Inc公司简介:Evolus Inc 是一家性能美容公司,以客户为中心,在自费美容市场提供突破性产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205230319861d2294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240205230319861d2294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI","EOLS"],"gpt_icon":0},{"id":"2407194862","title":"Evolus Inc盘中异动 早盘急速上涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407194862","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2407194862?lang=zh_cn&edition=full","pubTime":"2024-01-29 22:32","pubTimestamp":1706538733,"startTime":"0","endTime":"0","summary":"北京时间2024年01月29日22时32分,Evolus Inc股票出现波动,股价大幅拉升6.11%。Evolus Inc股票所在的制药行业中,整体涨幅为0.26%。其相关个股中,祁连国际、Sunshine Biopharma Inc C/Wts 15/02/2027 、Neptune Wellness Solutions Inc涨幅较大,Im Cannabis Corp、惠普森医药、Sonoma Pharmaceuticals Inc较为活跃,换手率分别为7.94%、2.52%、1.52%,振幅较大的相关个股有祁连国际、Sonoma Pharmaceuticals Inc、Sunshine Biopharma Inc C/Wts 15/02/2027 ,振幅分别为23.48%、21.99%、12.00%。Evolus Inc公司简介:Evolus Inc 是一家性能美容公司,以客户为中心,在自费美容市场提供突破性产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240129223213875982b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240129223213875982b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","EOLS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evolus.com","stockEarnings":[{"period":"1week","weight":0.0341},{"period":"1month","weight":0.1608},{"period":"3month","weight":0.0612},{"period":"6month","weight":0.0159},{"period":"1year","weight":0.5512},{"period":"ytd","weight":0.1519}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Evolus, Inc.于2012年11月在特拉华州注册成立。它是一家医学美学公司,致力于为医生及其患者提供审美程序和治疗方面的更多选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.325808},{"month":2,"riseRate":0.666667,"avgChangeRate":0.25383},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.105811},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.083767},{"month":5,"riseRate":0.857143,"avgChangeRate":0.386797},{"month":6,"riseRate":0.571429,"avgChangeRate":0.01257},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.007702},{"month":8,"riseRate":0.333333,"avgChangeRate":0.03384},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.145447},{"month":10,"riseRate":0.5,"avgChangeRate":-0.081151},{"month":11,"riseRate":0.5,"avgChangeRate":-0.013688},{"month":12,"riseRate":0.5,"avgChangeRate":-0.018253}],"exchange":"NASDAQ","name":"Evolus Inc.","nameEN":"Evolus Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evolus Inc.(EOLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Evolus Inc.(EOLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Evolus Inc.,EOLS,Evolus Inc.股票,Evolus Inc.股票老虎,Evolus Inc.股票老虎国际,Evolus Inc.行情,Evolus Inc.股票行情,Evolus Inc.股价,Evolus Inc.股市,Evolus Inc.股票价格,Evolus Inc.股票交易,Evolus Inc.股票购买,Evolus Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evolus Inc.(EOLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Evolus Inc.(EOLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}